Abstract: Education curricula materials include encoded indicia such as a QR code that contains information related to identifying requested augmented reality image data from a server over a network. By scanning the QR code, a computer uses its decoding software to create a data set for transmitting to the server. The data set may include an identifier for selected augmented reality image data associated with the user's curriculum, information about the curriculum at issue, the academic level of the user, and any other data necessary to ensure that the most appropriate augmented reality image data is transmitted back to the computer. The server transmits comprehensive augmented reality image data back to the computer for viewing on a computerized display accessible by a student. Part of the content may include an interactive pedagogical agent that helps the student with a part of the instruction related to a portion of the curriculum.

Abstract: Education curricula materials include encoded indicia such as a QR code that contains information related to identifying requested augmented reality image data from a server over a network. By scanning the QR code, a computer uses its decoding software to create a data set for transmitting to the server. The data set may include an identifier for selected augmented reality image data associated with the user's curriculum, information about the curriculum at issue, the academic level of the user, and any other data necessary to ensure that the most appropriate augmented reality image data is transmitted back to the computer. The server transmits comprehensive augmented reality image data back to the computer for viewing on a computerized display accessible by a student. Part of the content may include an interactive pedagogical agent that helps the student with a part of the instruction related to a portion of the curriculum.

Abstract: Education curricula materials include encoded indicia such as a QR code that contains information related to identifying requested augmented reality image data from a server over a network. By scanning the QR code, a computer uses its decoding software to create a data set for transmitting to the server. The data set may include an identifier for selected augmented reality image data associated with the user's curriculum, information about the curriculum at issue, the academic level of the user, and any other data necessary to ensure that the most appropriate augmented reality image data is transmitted back to the computer. The server transmits comprehensive augmented reality image data back to the computer for viewing on a computerized display accessible by a student. Part of the content may include an interactive pedagogical agent that helps the student with a part of the instruction related to a portion of the curriculum.

Abstract: A three-dimensional printed swab may include a shaft defining a longitudinal axis of the swab, and a tip portion integrally formed with the shaft. The tip portion may include a body extending outward from the shaft and positioned coaxially with the longitudinal axis, and a plurality of protrusions each extending outward from the body and transverse to the longitudinal axis. Alternatively, the tip portion may include a body extending outward from the shaft and positioned coaxially with the longitudinal axis, and a plurality of recesses each defined in the body and extending inward toward the longitudinal axis. As another alternative, the tip portion may include a body extending outward from the shaft and positioned coaxially with the longitudinal axis, and a series of annular ribs each extending outward from the body and positioned coaxially with the longitudinal axis.

Abstract: Education curricula materials include encoded indicia such as a QR code that contains information related to identifying requested augmented reality image data from a server over a network. By scanning the QR code, a computer uses its decoding software to create a data set for transmitting to the server. The data set may include an identifier for selected augmented reality image data associated with the user's curriculum, information about the curriculum at issue, the academic level of the user, and any other data necessary to ensure that the most appropriate augmented reality image data is transmitted back to the computer. The server transmits comprehensive augmented reality image data back to the computer for viewing on a computerized display accessible by a student. Part of the content may include an interactive pedagogical agent that helps the student with a part of the instruction related to a portion of the curriculum.

Abstract: Wood pulp is treated with an esterase formulation in combination with a metal ion or cationic polymer to increase the stability or activity or both of esterase enzymes at high temperature, or at extreme pH ranges of acidic and alkaline conditions. The treatment by esterase together with metals ion or cationic polymer can be used to treat pitch containing pulp at high temperatures prior to, during or after refining of wood chip/pulp, in order to enhance the reduction of pitch problems and facilitate in the manufacture of paper.

Abstract: Wood pulp is treated with an esterase formulation in combination with a metal ion or cationic polymer to increase the stability or activity or both of esterase enzymes at high temperature, or at extreme pH ranges of acidic and alkaline conditions. The treatment by esterase together with metals ion or cationic polymer can be used to treat pitch containing pulp at high temperatures prior to, during or after refining of wood chip/pulp, in order to enhance the reduction of pitch problems and facilitate in the manufacture of paper.

Abstract: Methods, systems and computer program products for assisting a visually-impaired user to view visual content.

Abstract: Wood pulp is treated with an esterase formulation in combination with a metal ion or cationic polymer to increase the stability or activity or both of esterase enzymes at high temperature, or at extreme pH ranges of acidic and alkaline conditions. The treatment by esterase together with metals ion or cationic polymer can be used to treat pitch containing pulp at high temperatures prior to, during or after refining of wood chip/pulp, in order to enhance the reduction of pitch problems and facilitate in the manufacture of paper.

Abstract: The present invention relates to monoclonal antibody H11 and antigen binding fragments that specifically bind to the antigen recognized by H11, the C-antigen. The C-antigen is found specifically on neoplastic cells and not on normal cells. Also disclosed are polynucleotide and polypeptide derivatives based on H11, including single chain V region molecules and fusion proteins, and various pharmaceutical compositions. When administered to an individual, the H11 antibody is effective in diagnosing, localizing, and/or treating neoplasias. The invention further provides methods for treating a neoplastic disease, particularly melanoma, neuroblastoma, glioma, soft tissue sarcoma, and small cell lung carcinoma. Patients who are in remission as a result of traditional modes of cancer therapy may be treated with a composition of this invention in hopes of reducing the risk of recurrence. Patients may also be treated concurrently with the antibodies and traditional anti-neoplastic agents.

Abstract: The present invention relates to monoclonal antibody H11 and antigen binding fragments that specifically bind to the antigen recognized by H11, the C-antigen. The C-antigen is found specifically on neoplastic cells and not on normal cells. Also disclosed are polynucleotide and polypeptide derivatives based on H11, including single chain V region molecules and fusion proteins, and various pharmaceutical compositions. When administered to an individual, the H11 antibody is effective in diagnosing, localizing, and/or treating neoplasias. The invention further provides methods for treating a neoplastic disease, particularly melanoma, neuroblastoma, glioma, soft tissue sarcoma, and small cell lung carcinoma. Patients who are in remission as a result of traditional modes of cancer therapy may be treated with a composition of this invention in hopes of reducing the risk of recurrence. Patients may also be treated concurrently with the antibodies and traditional anti-neoplastic agents.

Abstract: An optically clear, pharmaceutically acceptable aqueous composition comprising paclitaxel or a derivative thereof, serum albumin and a pharmaceutically acceptable vehicle, wherein the composition comprises no more than 10% organic solvent and has a pH of about 3.0 to about 4.8, is described. The serum albumin can be fatted or defatted, and the composition can optionally be lyophilized or optionally lyophilized and reconstituted. At least 70% of the paclitaxel is bound to serum albumin, the ratio of paclitaxel to albumin is at least about 1:5, and the concentration of paclitaxel is at least about 25 ?g/ml. Methods of making and using this composition an also provided.

Abstract: Phage display libraries are taught in which the recombinant phage population displays a plurality of potential binding fragments having preferred characteristics of solubility and/or intermolecular interaction. Also taught are methods of biasing display libraries to produce variants which more closely approximate the preferred characteristics of the parental binding fragment.

Abstract: A system for cooling at least one gas turbine liquid fuel component located in a high temperature environment to eliminate coking in the component is disclosed. The system includes a sleeve surrounding the liquid fuel component, a device for providing a current of cool air, and a conduit connected between the cool air device and the sleeve to direct the current of cool air into the sleeve to cool the liquid fuel component. The system can also include a manifold connected to the conduit and a plurality of second conduits for connecting the manifold to a plurality of sleeves surrounding a plurality of liquid fuel components, each sleeve being connected to a corresponding second conduit. Each sleeve includes a plurality of spacing devices for centering the sleeve around the at least one liquid fuel component so as to form an annulus between the sleeve and the liquid fuel component through which the current of cool air flows.

Abstract: The present invention relates to monoclonal antibody H11 and antigen binding fragments that specifically bind to the antigen recognized by H11, the C-antigen. The C-antigen is found specifically on neoplastic cells and not on normal cells. Also disclosed are polynucleotide and polypeptide derivatives based on H11, including single chain V region molecules and fusion proteins, and various pharmaceutical compositions. When administered to an individual, the H11 antibody is effective in diagnosing, localizing, and/or treating neoplasias. The invention further provides methods for treating a neoplastic disease, particularly melanoma, neuroblastoma, glioma, soft tissue sarcoma, and small cell lung carcinoma. Patients who are in remission as a result of traditional modes of cancer therapy may be treated with a composition of this invention in hopes of reducing the risk of recurrence. Patients may also be treated concurrently with the antibodies and traditional anti-neoplastic agents.

Abstract: The present invention relates to monoclonal antibody H11 and antigen binding fragments that specifically bind to the antigen recognized by H11, the C-antigen. The C-antigen is found specifically on neoplastic cells and not on normal cells. Also disclosed are polynucleotide and polypeptide derivatives based on H11, including single chain V region molecules and fusion proteins, and various pharmaceutical compositions. When administered to an individual, the H11 antibody is effective in diagnosing, localizing, and/or treating neoplasias. The invention further provides methods for treating a neoplastic disease, particularly melanoma, neuroblastoma, glioma, soft tissue sarcoma, and small cell lung carcinoma. Patients who are in remission as a result of traditional modes of cancer therapy may be treated with a composition of this invention in hopes of reducing the risk of recurrence. Patients may also be treated concurrently with the antibodies and traditional anti-neoplastic agents.

Abstract: A system for enabling a party maintaining a website on the Internet to engage in e-commerce sales transactions over the Internet without creating and supporting necessary transaction software. A second Internet-based server supports the transaction software and provides customized sections for a plurality of associated websites. Each of the associated websites includes links posted on a screen which enable access to the second Internet-based server so that page generated by the second server appear to be pages maintained on the first server. Parties communicating over the Internet with either the first or the second server can engage in e-commerce transactions with the party maintaining the first server. The second server may communicate with the enterprise software of the party maintaining the first server in order to enable and record the transactions.

Abstract: The present invention relates to monoclonal antibody H11 and antigen binding fragments that specifically bind to the antigen recognized by H11, the C-antigen. The C-antigen is found specifically on neoplastic cells and not on normal cells. Also disclosed are polynucleotide and polypeptide derivatives based on H11, including single chain V region molecules and fusion proteins, and various pharmaceutical compositions. When administered to an individual, the H11 antibody is effective in diagnosing, localizing, and/or treating neoplasias. The invention further provides methods for treating a neoplastic disease, particularly melanoma, neuroblastoma, glioma, soft tissue sarcoma, and small cell lung carcinoma. Patients who are in remission as a result of traditional modes of cancer therapy may be treated with a composition of this invention in hopes of reducing the risk of recurrence. Patients may also be treated concurrently with the antibodies and traditional anti-neoplastic agents.